PRFX

Healthcare Drug Manufacturers - Specialty & Generic

PRF Technologies Ltd.

$0.92

-0.05 -5.03% today

Price History

Not enough data

Key Stats

Market Cap

3.22M

Avg Volume

304,923

EPS

-$4.09

52W High

$7.95

52W Low

$0.85

Div. Yield

0.0%

Valuation

Forward P/E

-0.08

P/B Ratio

0.18

P/S Ratio

103.85

EV/EBITDA

1.91

EV/Revenue

-260.79

Margins

Gross Margin 0.0%

Operating Margin (18114.3%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(45.3%)

Return on Assets

(21.9%)

Liquidity & Leverage

Current Ratio

5.07

Quick Ratio

5.00

Debt / Equity

0.00

Total Cash

11.54M

Total Debt

50,000

About

PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.